| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.089 | 0.09 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.089 | 0.1 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.21 | 0.1 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |